Zacks Investment Research downgraded shares of GLOBUS MEDICAL (GMED) from NEUTRAL to UNDERPERFORM on December 19, 2012, with a target price of $11.00.
Globus Medical, Inc. is a medical device company focused on the design, development and commercialization of products that promote healing in patients with spine disorders. The Company's products fall into one of two categories: innovative fusion or disruptive technologies. Its innovative fusion products address a broad range of spinal fusion surgical procedures. Its disruptive technology products include minimally invasive surgical, motion preservation and advanced biomaterials technologies. Globus Medical, Inc. is based in Audubon, Pennsylvania.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on GLOBUS MEDICAL (GMED),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment